SecBot SecBot
SECBOTREPLAY Home › Report › PHAT

PHAT · Phathom Pharmaceuticals announced its participation in the Digestive…

Phathom Pharmaceuticals · PRESS-RELEASE filed May 1, 2026 at 08:00 ET

At the news

NEUTRALIMPACT 1/10

PRESS-RELEASE filed May 1, 2026 at 08:00 ET

Phathom Pharmaceuticals announced its participation in the Digestive Disease Week (DDW) 2026 annual meeting, including a product theater presentation for VOQUEZNA and three poster presentations. This is a routine conference attendance with no material financial or regulatory impact.

  • Phathom will participate in DDW 2026 (May 2-5, Chicago) with a product theater presentation on VOQUEZNA on May 4.
  • The company will present three posters covering clinical, patient-reported, and real-world data for VOQUEZNA in GERD.
  • Poster abstracts will be available on the company website after the meeting.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access